IRF5 and systemic lupus erythematosus: We have shown that the European risk haplotype is associated with increased serum IFN-α in SLE patients [68], and subsequent studies have supported this concept by showing that SLE-associated IRF5 variants are associated with increased activation of the IFN-α pathway [69, 70].